EFFICACY AND SAFETY OF COVID-19 VACCINES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH DIFFERENT ANTI-RHEUMATIC THERAPIES

被引：0
|
作者：
Su, Q. Y. [1 ,2 ,3 ]
Luo, J. [2 ,3 ]
Zhang, Y. [2 ,3 ]
Zhao, B. R. [2 ,3 ]
Cao, Y. [2 ,3 ]
Yu, Q. [4 ]
He, P. F. [4 ]
Li, X. [1 ,2 ,3 ]
Zhang, S. X. [1 ,2 ,3 ]
机构：
[1] Shanxi Med Univ, Dept Rheumatol, Hosp 2, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Acad Microbial Ecol, Taiyuan, Peoples R China
[3] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan, Peoples R China
[4] Minist Educ, Shanxi Key Lab Big Data Clin Decis Res, Taiyuan, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
基金：
中国国家自然科学基金;
关键词：
Rheumatoid arthritis; COVID; Vaccination/immunization;
D O I：
10.1136/annrheumdis-2023-eular.4290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1317
引用
收藏
页码：1888 / 1888
页数：1
相关论文
共 50 条
  • [1] COVID-19: an unexpected indication for anti-rheumatic therapies?
    Lucchino, Bruno
    Di Franco, Manuela
    Conti, Fabrizio
    RHEUMATOLOGY, 2020, 59 (06) : 1200 - 1203
  • [2] SAFETY OF COVID-19 VACCINES IN PATIENTS WITH RHEUMATOID ARTHRITIS (PRELIMINARY DATA).
    不详
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1665 - 1665
  • [3] Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis
    Ma, Kexun
    Li, Ling
    Liu, Chunhui
    Zhou, Lingling
    Zhou, Xueping
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (01) : 33 - 54
  • [4] Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation
    Ngian, Gene-Siew
    Briggs, Andrew M.
    Ackerman, Ilana N.
    Van Doornum, Sharon
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 834 - 843
  • [5] LOSS OF EFFICACY OF ANTI-RHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS
    ROSENTHAL, M
    JOURNAL OF RHEUMATOLOGY, 1980, 7 (04) : 586 - 587
  • [6] IMMUNOGENICITY AND SAFETY OF ADJUVANTED RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH DISEASEMODIFYING ANTI-RHEUMATIC DRUGS
    Kojima, S.
    Iwamoto, T.
    Kobayashi, Y.
    Kato, M.
    Takizawa, F.
    Ida, T.
    Toda, Y.
    Miyachi, K.
    Suzuki, J.
    Iwata, A.
    Furuta, S.
    Ikeda, K.
    Suzuki, K.
    Nakajima, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 554 - 555
  • [7] COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
    Ouedraogo, Dieu-Donne
    Tiendrebeogo, Wendlassida Joelle Stephanie
    Kabore, Fulgence
    Ntsiba, Honore
    CLINICAL RHEUMATOLOGY, 2020, 39 (07) : 2069 - 2075
  • [8] COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
    Dieu-Donné Ouédraogo
    Wendlassida Joelle Stéphanie Tiendrébéogo
    Fulgence Kaboré
    Honoré Ntsiba
    Clinical Rheumatology, 2020, 39 : 2069 - 2075
  • [9] Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis
    Alpay-Kanitez, Nilufer
    Pehlivan, Ozlem
    Omma, Ahmet
    Can-Sandikci, Sevinc
    Girgin, Sinem
    Icacan, Ozan Cemal
    Celik, Selda
    Bes, Cemal
    MEDICINE, 2020, 99 (16) : E19696
  • [10] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
12345